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Abstract 34 
Objectives: To examine which inflammatory markers are associated with bone mass and 35 
whether this association varies according to muscular fitness in children with 36 
overweight/obesity.  37 
Methods: Plasma interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNF-α), epidermal 38 
growth factor, vascular endothelial growth factor A (VEGF) and C-reactive protein were 39 
analyzed in 55 children (38 boys) aged 8 to 11 yr. Muscular fitness was computed as the 40 
mean of the 1 maximum repetition in bench press and leg press standardized values. Fat 41 
mass, lean mass, and bone mineral content (BMC) of the total body less head (TBLH) 42 
and lumbar spine (LS) were assessed using dual-energy x-ray absorptiometry.  43 
Results: IL-6 (β = -0.136) and VEGF (β = -0.099) were associated with TBLH BMC, 44 
whilst TNF-α (β = -0.345) and IL-1β (β = 0.212) were associated with LS BMC after 45 
controlling for potential cofounders (P < 0.05). There was a trended interaction of 46 
muscular fitness in the association of VEGF with TBLH BMC (P = 0.122) and TNF-α 47 
with LS BMC (P = 0.057). Stratified analyses by muscular fitness levels showed an 48 
inverse association of VEGF with TBLH BMC (β = -0.152, P = 0.032) and TNF-α with 49 
LS BMC (β = -0.491, P < 0.001) in the low-fitness group, whilst no evidence of 50 
association was found in the high-fitness group.  51 
Conclusion: IL-6, VEGF, TNF-α, and IL-1β are significantly associated with bone mass. 52 
Higher muscular fitness may attenuate the adverse effect of high levels of VEGF and 53 
TNF-α on bone in this population. 54 
Key words: cytokines, growth factors, bone health, strength, childhood obesity  55 
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Introduction 56 
Obesity and osteoporosis are two major global health problems with an increasing 57 
prevalence and closely related to both mortality and morbidity worldwide (1,2). The belief 58 
that obesity is protective against osteoporosis has recently come into question due to the 59 
increasing evidence about the endocrine function and interplay between different tissues, 60 
such as muscular, adipose, and bone tissue (3). Moreover, childhood is a critical period 61 
for bone accretion (4) and reaching an optimal peak bone mass is considered the best 62 
protective factor against future osteoporosis and fracture.  63 
The link between body composition and bone health in children and adolescents 64 
has been the focus of various investigations over the last few decades (5). Previous cross-65 
sectional evidence highlights a negative association between fat mass (FM) and bone 66 
mass in adolescents, once lean mass (LM) is accounted for (6). In addition, Mengel et al. 67 
(7) observed that boys with overweight/obesity who had an extensive body mass index 68 
(BMI) gain during puberty experienced lower gains in bone outcomes. In this regard, the 69 
increasing presence of fat within the bone marrow is known to affect osteoblast 70 
differentiation, increasing osteoclastic activity and affecting mineralization (8).  71 
The pediatric skeleton is sensitive to factors that influence bone accrual, including 72 
physical activity and increased inflammatory cytokines (9). In this sense, the role that 73 
inflammatory markers play in the child’s skeleton has been investigated (10–12). For 74 
instance, Mengel et al. (11) found that vascular endothelial growth factor was inversely 75 
associated with total body bone mineral content (BMC), whereas epidermal growth factor 76 
(EGF) was inversely associated with areal bone mineral density (aBMD) and apparent 77 
bone mineral density  at the lumbar spine (LS). Similar to adipose tissue, the skeletal 78 
muscle is a secretory organ responsible for the production of several hundreds of 79 
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myokines in response to exercise (13). Thus, the muscle-adipose tissue axis should be 80 
taken into consideration to elucidate the systemic effects of the inflammatory markers on 81 
bone health. 82 
Muscular fitness has been favorably associated with potential health benefits (i.e. 83 
bone health, mental health, total and central adiposity, cardiovascular disease and 84 
metabolic risk factors) in children and adolescents (14). Recent studies reported that the 85 
association between muscular fitness and bone outcomes was explained by LM in 86 
different growth stages (15–17). In addition, muscular fitness has been inversely 87 
associated with c-reactive protein (CRP) in adolescents with overweight/obesity (18,19) 88 
and also in prepubertal children (20). In adolescents, a clustered score of inflammatory 89 
markers including CRP, C3, C4, fibrinogen, and leptin has been inversely associated with  90 
muscular fitness (21). 91 
To the best of our knowledge, no study has tested the role of muscular fitness in the 92 
association between inflammatory markers and bone mass. Therefore, the purpose of this 93 
study was twofold: 1) to identify which inflammatory markers are associated with bone 94 
mass in children with overweight/obesity and, 2) to examine whether this association 95 
varies according to muscular fitness levels in this population. 96 
Material and methods 97 
Participants and study design 98 
The present cross-sectional study was developed within the ActiveBrains project 99 
framework (ClinicalTrial.gov ID: NCT02295072). A detailed description of the study 100 
design, purpose, methodology and inclusion/exclusion criteria has been published 101 
elsewhere (22). The ActiveBrains project measured 110 prepubertal children with 102 
overweight/obesity from Granada (Southern Spain). Participants were recruited from the 103 
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Paediatric Unit of the University Hospitals San Cecilio and Virgen de las Nieves. The 104 
study protocol was approved by the Review Committee for Research Involving Human 105 
Subjects at the University of Granada (Reference: 848, February 2014) and informed 106 
consent was obtained from parents. 107 
In this report, a total of 55 children (10.2±1.2 years, 38 boys) with complete data 108 
on inflammatory markers, body composition (i.e. bone, FM and LM), objectively 109 
measured muscular fitness, and sexual maturation assessment were included (see 110 
flowchart in Figure 1). 111 
Anthropometry and sexual maturation 112 
Body mass (kg) was measured with an electronic scale (SECA 861, Hamburg, 113 
Germany). Height (cm) and sitting height were measured with a precision stadiometer 114 
(SECA 225, Hamburg, Germany). BMI was calculated as: body mass (kg)/height (m2) 115 
and the participants were classified into BMI categories according to the World Obesity 116 
Federation criteria (23).  117 
Somatic maturity offset was assessed as years from peak height velocity (PHV) 118 
from age, height and sitting height using validated algorithms for children (24).  119 
Inflammatory markers 120 
Venous blood samples were obtained between 08:00 a.m. and 09:00 a.m. by 121 
venipuncture after an overnight fast (at least 12 hours) in all participants. Blood samples 122 
in tubes containing EDTA were spun immediately at 1000g for 10 min. Plasma was 123 
isolated and stored at -80ºC until analyses. Three key cytokines analyzed in plasma were 124 
included in this study: interleukin-6 (IL-6, pg/mL), interleukin-1β (IL-1β, pg/mL), and 125 
tumor necrosis factor-α (TNF-α, pg/mL). IL-6, IL-1β and TNF-α were quantified by 126 
multiple analyte profiling technology (MILLIPLEX® MAP Human High Sensitivity T 127 
7 
 
Cell Magnetic Bead Panel, EMD Millipore Corporation, Missouri, USA) with a kit plex 128 
(HCYIL6-MAG Anti-Human IL-6 Beads set, HCYIL1B-MAG Anti-Human IL-1β Bead, 129 
and HCYTNFA-MAG Anti-Human TNF-α Beads set), using one 96-Well plate with 130 
sealers (Cat. HSTCMAG-28SK). The intra- and inter-assay precision coefficients of 131 
variation for IL-6 were 5% and 20%, respectively, and sensitivity was 0.11 pg/mL. For 132 
both, IL-1β and TNF-α the intra- and inter-assay precision coefficients of variation were 133 
5% and 15%, respectively, with a sensitivity of 0.14 pg/mL for IL-1β, and of 0.16 pg/mL 134 
for TNF-α. CRP (mg/L) was determined by turbidimetry (AU2700 Olympus Analyzer; 135 
Olympus UK Ltd, Watford, UK) with a sensitivity of 0.007 mg/L and inter-assay 136 
coefficients of variation 1.9%. 137 
Two growth factors were analyzed by multiple analyte profiling technology 138 
(MILLIPLEX® MAP Human Angiogenesis/Growth Factor Magnetic Bead Panel 1, EMD 139 
Millipore Corporation, Missouri, USA) with a kit plex (HVEGF-MAG Anti-Human 140 
VEGF-A Bead, and HAGEGF-MAG Anti-Human EGF Bead), using two 96-Well plates 141 
with sealers (Cat. HAGP1MAG-12K). The intra- and inter-assay precision coefficients 142 
of variation for vascular endothelial growth factor A (VEGF, pg/mL) were 3.5% and 10%, 143 
respectively, and sensitivity was 8.1 pg/mL. For EGF (pg/mL), the intra- and inter-assay 144 
precision coefficients of variation were 3.2% and 6.8%, respectively, with a sensitivity of 145 
1.0 pg/mL.  146 
Body composition 147 
Children were scanned with dual-energy X-ray Absorptiometry (DXA) using the 148 
Hologic Discovery Wi (Hologic Series Discovery QDR, Bedford, MA, USA). The DXA 149 
equipment was calibrated at the start of each testing day by using a lumbar spine phantom 150 
as recommended by the manufacturer. All DXA scans and analyses were performed using 151 
8 
 
the GE encore software (version 4.0.2) and were completed following the same protocol 152 
by the same researcher. The positioning of the participants and the analyses of the results 153 
were undertaken following recommendations from the International Society of Clinical 154 
Densitometry (25). The total body scan was used to obtain FM, LM, and BMC at the total 155 
body less head (TBLH) and at the LS. 156 
Objectively measured muscular fitness 157 
Muscular fitness was evaluated in laboratory conditions. We determined each 158 
participant's 1 repetition maximum (1RM) when the child was able to lift throughout the 159 
full range of motion in bench press and leg press tests (26). Participants received 160 
familiarization sessions before the testing session in order to ensure an adequate technique 161 
(i.e. controlled movements and proper breathing). Before attempting 1RM, participants 162 
performed 6 repetitions with a light load and 3 repetitions with a heavier load (50–90% 163 
estimated 1RM). Then, a series of single repetitions with increasing loads (0.5–2.3 kg for 164 
bench press and 10–20 kg for leg press) were performed. The 1RM was determined when 165 
participants fell short of the full range of motion on at least two non-consecutive attempts. 166 
A resting time of 3–5 minutes between attempts was allowed. Rate of perceived exertion 167 
at each attempt was obtained using the children's OMNI-Resistance Exercise scale (27). 168 
Moreover, during all testing procedures researchers obtained more information from the 169 
participants by asking questions such as: “How do you feel?”, “Is the load light, medium 170 
or heavy?” and “Could you lift more?” to aid in the progression of the 1RM trials.  171 
A muscular fitness score was computed by combining the standardized values of 172 
1RM bench press and 1RM leg press tests. Each of these variables was standardized as 173 
follows: standardized value=(value−mean)/SD. The muscular fitness z-score was 174 
calculated as the mean of the 2 standardized scores (1RM bench press and 1RM leg press). 175 
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Statistical analyses 176 
Data were analyzed using SPSS IBM statistics (version 20 for Windows, Chicago, 177 
IL) and the normal distribution of the raw variables was confirmed using visual check of 178 
histograms, Q-Q and box plots. Statistical significance was defined as P<0.05. Interaction 179 
analyses were performed between sex and inflammatory markers on the outcomes. No 180 
significant interactions were found (P>0.05), so analyses were carried out for boys and 181 
girls together. 182 
Descriptive characteristics of participants are presented as mean ± standard 183 
deviation (SD). Differences between sexes were determined by independent t tests. 184 
Stepwise hierarchical regression analyses were carried out to identify the inflammatory 185 
markers that best predicted bone mass. Sex, years from PHV and TBLH LM were 186 
considered for entry into step 1 of the model, and subsequent addition of inflammatory 187 
markers in step 2 was conducted to determine the contribution to the bone mass variables 188 
following step 1 adjustments. These covariates were selected because of their known 189 
association with bone mass (6). The standardized regression coefficients (β) are reported 190 
and the squared semi-partial correlation coefficients (sr2) were used to determine the 191 
contribution of each predictor in the overall variance of the model after removing shared 192 
contributions with other predictors. Collinearity was checked for the variables using the 193 
variance inflation factor and tolerance levels. 194 
Finally, multiple linear regression analysis with interaction effect was used to test 195 
the role of muscular fitness in the association between inflammatory markers (those that 196 
were significant in the stepwise regression models) and bone mass. The interaction effects 197 
of muscular fitness in the association between inflammatory markers and bone mass were 198 
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further examined (in those with P<0.20), stratifying by high/low (above/below sex-, age-199 
, and study-specific median) levels of muscular fitness. 200 
Results 201 
Descriptive characteristics are presented in Table 1 (mean ± SD). Girls were more 202 
mature than boys (P < 0.05) but no significant differences between sexes were found in 203 
the remaining descriptive variables. The mean age of the participants was 10±1.2 years 204 
and they were 2.3±1.0 years below PHV, overweight and obesity was evident in 30.9% 205 
and 69.1% of them, respectively. 206 
Table 2 shows the stepwise multiple regression analyses for identifying the 207 
inflammatory markers that explained the variance in the outcome variables in children 208 
with overweight/obesity. The probability of F-to-remove ≥ 0.1 was established in order 209 
to identify these markers. For TBLH BMC, 88% of the variance was explained by TBLH 210 
LM, years from PHV, IL-6, sex, and VEGF (sr2 = 0.009 – 0.135), whilst 66% of the 211 
variance in LS BMC was explained by TNF-α, years from PHV, TBLH LM, IL-1β, and 212 
sex (sr2 = 0.001 – 0.096). 213 
The role of muscular fitness z-score in the association of inflammatory markers 214 
(those previously included in the stepwise method) and bone mass is shown in Table 3. 215 
After adjusting for sex, years from PHV, and TBLH LM, the interaction effect of 216 
muscular fitness showed a positive trend in the association of VEGF with TBLH BMC 217 
(P = 0.122) and TNF-α with LS BMC (P = 0.057). No evidence of interaction with 218 
muscular fitness was found in the remaining associations of IL-6 with TBLH BMC (P = 219 
0.857) and IL-1β with LS BMC (P = 0.309). 220 
Figure 2 shows the standardized β regression slopes of VEGF with TBLH BMC 221 
and TNF-α with LS BMC, according to muscular fitness levels. Stratified analyses by 222 
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muscular fitness levels (below/above median) showed a significant inverse association 223 
between VEGF and TBLH BMC in the low muscular fitness group (Figure 2A, β = -224 
0.152, P = 0.032), whilst no evidence of association was found in the high muscular 225 
fitness group (Figure 2A, β = -0.045, P = 0.598). Likewise, an inverse association between 226 
TNF-α and LS BMC was found in the low muscular fitness group (Figure 2B, β = -0.491, 227 
P < 0.001), although this association was non-significant in the high muscular fitness 228 
group (Figure 2B, β = -0.060, P = 0.666). 229 
Discussion 230 
In the present study we showed IL-6 and VEGF to be associated with TBLH BMC 231 
and TNF-α and IL-1β with LS BMC in children with overweight/obesity. In addition, our 232 
results suggested that higher levels of muscular fitness may attenuate the adverse effects 233 
of VEGF and TNF-α on TBLH BMC and LS BMC, respectively. To the best of our 234 
knowledge, this is one of the few studies which thoroughly addresses the influence of 235 
inflammatory markers on bone mass, and the first study examining the role of muscular 236 
fitness in the relationship between inflammatory markers and bone mass. 237 
Inflammatory markers and bone mass in overweight/obese children 238 
In this study, an inverse association between VEGF and TBLH BMC was found 239 
after controlling for the effect of sex, years from PHV, and TBLH LM. Our results were 240 
comparable to a longitudinal study  in which serum VEGF was inversely associated with 241 
BMC/height at the total body in boys with overweight whose BMI gain was higher during 242 
pubertal years (11). Elevated circulating levels of VEGF have been found in obese 243 
population as hypoxia-induced by adipose tissue expansion produce VEGF (28). 244 
However, VEGF functions on bone development depend both on autocrine and paracrine 245 
pathways. For instance, VEGF stimulates osteoblast differentiation and inhibits 246 
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adipocytes differentiation via intracrine pathway, whereas osteoblast-derived VEGF 247 
leads osteoclast differentiation via paracrine pathway (29). In the light of these findings, 248 
we could speculate that despite VEGF concentrations are important for the adipose tissue 249 
vascularization in this population, highly-expressed VEGF as a consequence of the 250 
overweight/obese condition might have detrimental effects on bone mass accumulation, 251 
possibly explained by the dysregulation of autocrine and paracrine mechanisms. 252 
IL-6 was also inversely associated with TBLH BMC after controlling for the same 253 
set of cofounders. Our results are in accordance with Hanks et al. (10) who found a 254 
negative correlation between IL-6 and BMC in prepubertal girls. Similarly, Mengel et al. 255 
(11) found that the changes in serum IL-6 were negatively correlated with LS aBMD in 256 
boys with overweight and extensive BMI gain during the pubertal years. However, they 257 
did not find any association between IL-6 and LS aBMD after controlling for the effect 258 
of testosterone, body fat percentage, and BMI. Previous studies have reported that IL-6 259 
directly promotes osteoclastogenesis by binding with receptors on pre-osteoclasts or 260 
indirectly alters bone remodeling by inducing JAK/STAT3 pathways through osteoblasts 261 
and secrete pro-osteoclasts mediators (i.e. receptor activator of nuclear factor kappa-Β 262 
ligand [RANKL], and IL-1) (30). Overall, our findings agree with the idea that IL-6 have 263 
anti-osteogenic and pro-osteoclastic effects on bone and these effects might already be 264 
present in prepubertal children with overweight/obesity. 265 
Like IL-6, in vitro studies have also reported the osteoclastogenic role of TNF-α 266 
(31). Otherwise, few studies have documented this role in humans. Zheng et al (32) 267 
reported that TNF-α produced by stimulated whole blood cells was inversely associated 268 
with LS aBMD in postmenopausal women, whereas Ding et al (33) found that the inverse 269 
association between serum TNF-α and LS aBMD in older men disappeared after 270 
controlling for IL-6. Our results indicate that plasma levels of TNF-α were inversely 271 
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associated with LS BMC independently on sex, years from PHV, and TBLH LM. Besides, 272 
IL-6 did not come up as a predictor of LS BMC in the stepwise multiple linear regression.  273 
IL-1β is a proinflammatory marker associated with osteoclastogenesis via induction 274 
of RANKL and inhibition of osteoprotegerin and reduces osteoblast recruitment in vitro 275 
(34). Unexpectedly our results suggest, for the first time, a positive association between 276 
IL-1β and LS BMC after controlling for potential cofounders in children with 277 
overweight/obesity. This finding agrees with the study of  Pacifici et al. (35) in which an 278 
increased IL-1 production was associated with bone formation in adults independently on 279 
sex and menopausal status. This can be explained by the fact that short stimulation of 280 
mesenchymal stem cells with IL-1β leads to osteogenic differentiation through 281 
upregulation of genes in MG63-GFP osteoblasts (36). On the contrary, IL-1β has been 282 
negatively associated with LS aBMD in postmenopausal women (32) and Mengel et al. 283 
(11) did not find significant associations between IL-1β and aBMD in overweight 284 
children.  285 
Muscular fitness, inflammatory markers and bone mass in overweight/obese children 286 
Bone marrow is a complex environment, in which a variety of cell types (i.e. blood 287 
cells, osteoblasts, osteoclasts, and adipocytes) share a common space locally releasing 288 
cytokines and growth factors that could affect the cells in their proximity (8). 289 
Furthermore, bone development is regulated by modelling and remodeling processes that 290 
depend on the mechanical forces applied by the muscles to the skeleton (37). Our study 291 
suggests that higher levels of muscular fitness might attenuate the detrimental effects of 292 
VEGF and TNF-α on TBLH BMC and LS BMC, respectively (Figure 2). In this regard, 293 
partial correlations controlling for sex and years from PHV showed that VEGF was 294 
negatively correlated with muscular fitness (data not shown, r = -0.36, P = 0.008), 295 
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although no evidence of correlation was found between TNF-α and muscular fitness (data 296 
not shown, r = -0.01, P = 0.923). The latter result contrasts with Steene-Johannessen et 297 
al. (20) who found a negative correlation between TNF-α and muscular fitness in 298 
prepubertal children after controlling for pubertal stage. Nevertheless, the beneficial 299 
effect of muscular fitness on bone development is well documented in growing children 300 
(38). Moreover, the association between muscular fitness and bone mass is mediated by 301 
LM in prepubertal children (15). Likewise, an inhibitory effect of LM on obesity-related 302 
inflammation has been suggested in middle-aged adults (39). Thereby, our finding agrees 303 
with literature and supports the fact that there is a crosstalk between adipocytes and 304 
myocytes interacting with obesity and its related-disorders even in children with 305 
overweight/obesity. We speculate that the detrimental consequences of excessive FM (i.e. 306 
inflammation) in children with overweight/obesity could be counteracted, to some extent, 307 
by maintaining optimal levels of muscular fitness. 308 
Strengths and limitations 309 
Some limitations need to be considered. At first, our cross-sectional design rules 310 
out the possibility of identifying cause-effect relationships. Secondly, the number of 311 
participants with complete data in all studied variables is relatively small, but similar to 312 
previous studies (11,12). Thirdly, our study has used plasma samples to measure 313 
inflammatory markers. Previous studies have used plasma or serum samples and 314 
therefore, comparisons may be affected. However, as shown in a recent study the 315 
correlations between plasma and serum measurements suggest that the differences in 316 
metabolite concentrations does not necessarily introduce a bias in cross-sectional studies 317 
(40). Notwithstanding, the use of DXA and the accuracy of the objective methodology 318 
used for muscular fitness and blood measurements are strengths of this study. 319 
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Conclusion 320 
In summary, our findings suggest that the link between obesity and bone health may 321 
be at least explained by inflammatory mechanisms in children with overweight/obesity. 322 
Specifically, IL-6 and VEGF were negatively associated with TBLH BMC, whereas 323 
TNF-α (negatively) and IL-1β (positively) were associated with LS BMC. Furthermore, 324 
our data suggest that high levels of objectively measured muscular fitness may attenuate 325 
the adverse effects of VEGF and TNF-α on TBLH BMC and LS BMC, respectively. In 326 
the light of these findings, appropriate levels of muscular fitness may preserve normal 327 
bone accretion in this population. Future longitudinal and intervention studies in this 328 
population are needed to confirm these findings.  329 
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Figure 1. Flowchart of study participants. 475 
DXA dual-energy x-ray absorptiometry; 1RM one repetition maximum. 476 
 477 
Figure 2. Graphical representation of the standardized regression slopes between VEGF 478 
and TBLH BMC by levels of muscular fitness (A); and between TNF-α and LS BMC 479 
by levels of muscular fitness (B). High/low fitness groups were defined as being 480 
above/below the age, sex and study-specific median values for average muscular fitness 481 
z-score†. The regression models were adjusted for sex, years from PHV, and TBLH LM. 482 
The standardized coefficients are interpreted as the number of SDs that the outcome 483 
changes as a result of 1-SD change in the predictor. 484 
† Z-score mean computed from 1RM bench press (kg) and 1RM leg press (kg) tests 485 
PHV peak height velocity; VEGF vascular endothelial growth factor A; TNF-α tumor 486 
necrosis factor alpha; TBLH total body less head; BMC bone mineral content; LM lean 487 
mass 488 
